Treatment of chronic hepatitis B with interferon alfa-2b.

[1]  M. Rizzetto,et al.  Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial. , 1988, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

[2]  J. Hoofnagle,et al.  Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B , 1988 .

[3]  F. T. ten Kate,et al.  Long-term follow-up of antiviral combination therapy in chronic hepatitis B. , 1988, American Journal of Medicine.

[4]  K. Meyer zum Büschenfelde,et al.  [Treatment of hepatitis B surface antigen (HBsAg)-positive chronic hepatitis with recombinant alpha-A-interferon. Results of a phase II study]. , 1988, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.

[5]  H. Klein,et al.  Virostatische Therapie der chronischen Hepatitis , 1988 .

[6]  H. Deicher,et al.  Clinical Significance of Neutralizing Antibodies in Patients with Chronic Myelogenic Leukemia , 1988 .

[7]  J. Bartolomé,et al.  Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon. , 2008, Liver.

[8]  V. Carreño,et al.  COMBINATION OF RECOMBINANT INTERFERONS ALPHA AND GAMMA IN TREATMENT OF CHRONIC HEPATITIS B , 1987, The Lancet.

[9]  H. Thomas,et al.  INTERFERONS AS MEDIATORS OF PSYCHIATRIC MORBIDITY An Investigation in a Trial of Recombinant α-Interferon in Hepatitis-B Carriers , 1987, The Lancet.

[10]  Ching-lung Lai,et al.  PLACEBO-CONTROLLED TRIAL OF RECOMBINANT α2-INTERFERON IN CHINESE HBsAg-CARRIER CHILDREN , 1987, The Lancet.

[11]  S. Ramón y. Cajal,et al.  A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules. , 1987, Antiviral research.

[12]  G. Garcia,et al.  Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial. , 1987, Annals of internal medicine.

[13]  R. Müller.  [Antiviral therapy in chronic hepatitis B]. , 1987, Medizinische Klinik.

[14]  M. Tong,et al.  A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B , 1986, Hepatology.

[15]  V. Barnaba,et al.  Effect of 28 consecutive days lymphoblastoid interferon (alpha-IFN) administration on hepatitis B virus related chronic liver disease. , 1986, Journal of hepatology.

[16]  M. Gebel,et al.  Antiviral treatment in chronic hepatitis B. Data of 5 prospectively controlled randomized trials. , 1986, Journal of hepatology.

[17]  A. Dibisceglie,et al.  Recombinant leucocyte interferon treatment of chronic hepatitis B. An analysis of two therapeutic trials. , 1986, Journal of hepatology.

[18]  A. Lok,et al.  Interferon therapy of chronic hepatitis B virus infection in Chinese. , 1986, Journal of hepatology.

[19]  H. Thomas,et al.  Lymphoblastoid and recombinant alpha-A interferon therapy of chronic hepatitis B virus infection. The Royal Free Hospital experience. , 1986, Journal of hepatology.

[20]  Roger Williams,et al.  Quantitation of hepatitis B virus DNA (HBV DNA) in serum using the spot hybridization technique and scintillation counting. , 1985, Journal of virological methods.

[21]  A. Dibisceglie,et al.  Recombinant leukocyte interferon treatment of chronic hepatitis B , 1985, Hepatology.

[22]  T. Merigan,et al.  Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection. , 1982, JAMA.

[23]  T. Merigan,et al.  Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. , 1981, Gastroenterology.

[24]  F. Schmidt,et al.  RAPID WITHDRAWAL OF IMMUNOSUPPRESSIVE THERAPY IN CHRONIC ACTIVE HEPATITIS B INFECTION , 1981, The Lancet.

[25]  T. Merigan,et al.  Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. , 1981, The Journal of infectious diseases.